[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE355286T1 - Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel - Google Patents

Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel

Info

Publication number
ATE355286T1
ATE355286T1 AT02734989T AT02734989T ATE355286T1 AT E355286 T1 ATE355286 T1 AT E355286T1 AT 02734989 T AT02734989 T AT 02734989T AT 02734989 T AT02734989 T AT 02734989T AT E355286 T1 ATE355286 T1 AT E355286T1
Authority
AT
Austria
Prior art keywords
sup
formula
group
residue
general formula
Prior art date
Application number
AT02734989T
Other languages
English (en)
Inventor
Ales Halama
Ludmila Hejtmankova
Petr Lustig
Jindrich Richter
Lucie Srsnova
Josef Jirman
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20011501A external-priority patent/CZ290353B6/cs
Priority claimed from CZ20011502A external-priority patent/CZ291364B6/cs
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE355286T1 publication Critical patent/ATE355286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
AT02734989T 2001-04-26 2002-04-25 Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel ATE355286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20011501A CZ290353B6 (cs) 2001-04-26 2001-04-26 Způsob výroby meziproduktu pro výrobu antidiabetika
CZ20011502A CZ291364B6 (cs) 2001-04-26 2001-04-26 Způsob výroby antidiabetika

Publications (1)

Publication Number Publication Date
ATE355286T1 true ATE355286T1 (de) 2006-03-15

Family

ID=25746959

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02734989T ATE355286T1 (de) 2001-04-26 2002-04-25 Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel

Country Status (11)

Country Link
US (1) US7009057B2 (de)
EP (1) EP1387843B1 (de)
AT (1) ATE355286T1 (de)
AU (1) AU2002311057A1 (de)
DE (1) DE60218449D1 (de)
EE (1) EE200300519A (de)
HU (1) HUP0400091A2 (de)
PL (1) PL363738A1 (de)
RU (1) RU2281285C2 (de)
SK (1) SK14452003A3 (de)
WO (1) WO2002088120A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993773B2 (en) 2002-07-16 2015-03-31 Cadila Healthcare Limited Process to prepare pioglitazone via several novel intermediates
DE60316152D1 (de) * 2002-07-16 2007-10-18 Cadila Healthcare Ltd Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
WO2004108721A1 (en) * 2003-04-01 2004-12-16 Sun Pharmaceutical Industries Limited Process for the preparation of 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl] methyl]-2,4-thiazolidinedione
ES2219180B1 (es) 2003-05-09 2006-03-01 Medichem, S.A. Compuesto intermedio util para la preparacion de pioglitazona.
US7230016B2 (en) 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2004101560A1 (en) * 2003-05-13 2004-11-25 Synthon B.V. Processes for making thiazolidinedione derivatives and compounds thereof
US20070078170A1 (en) * 2003-08-28 2007-04-05 Khanduri Chandra H Process for the preparation of pioglitazone
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
EP1716144A2 (de) 2004-02-20 2006-11-02 Synthon B.V. Verfahren zur herstellung von pioglitazon und verbindungen des verfahrens
US7402713B2 (en) * 2006-03-07 2008-07-22 E.I. Du Pont De Nemours And Company Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene
MX2008011871A (es) 2006-03-16 2009-02-10 Metabolic Solutions Dev Compan Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
CA2646149A1 (en) 2006-03-16 2007-09-27 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
KR100791400B1 (ko) 2006-09-06 2008-01-07 동우신테크 주식회사 티아졸리딘디온 유도체의 제조방법
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
CN101848901B (zh) 2007-09-14 2012-11-21 新陈代谢解决方案开发公司 用于治疗高血压的噻唑烷二酮类似物
WO2009148195A1 (en) * 2008-06-02 2009-12-10 Daebong Ls, Ltd. 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same
RU2564661C2 (ru) 2009-12-15 2015-10-10 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Соли тиазолидиндиона со сниженным сродством к ppar для лечения нарушений обмена веществ
CN108003090A (zh) * 2018-01-05 2018-05-08 白银亿尔精细化工有限公司 一种制备4-[2-(5-乙基-2-吡啶基)乙氧基]硝基苯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209274A (en) 1981-06-16 1982-12-22 Takeda Chem Ind Ltd Urea derivative, its preparation and its use
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPS62205054A (ja) 1986-03-05 1987-09-09 Takeda Chem Ind Ltd 尿素誘導体
US5952509A (en) 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
JP4316787B2 (ja) * 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、

Also Published As

Publication number Publication date
RU2281285C2 (ru) 2006-08-10
PL363738A1 (en) 2004-11-29
EE200300519A (et) 2004-02-16
US20050043360A1 (en) 2005-02-24
WO2002088120A1 (en) 2002-11-07
EP1387843A1 (de) 2004-02-11
AU2002311057A1 (en) 2002-11-11
SK14452003A3 (sk) 2004-04-06
WO2002088120B1 (en) 2004-02-26
DE60218449D1 (de) 2007-04-12
RU2003134542A (ru) 2005-06-10
EP1387843B1 (de) 2007-02-28
US7009057B2 (en) 2006-03-07
HUP0400091A2 (hu) 2004-06-28

Similar Documents

Publication Publication Date Title
ATE355286T1 (de) Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel
MEP7808A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
ATE348814T1 (de) Verfahren zur herstellung von chinolinderivaten
DE50005699D1 (de) Verfahren zur herstellung von thiazolidin
ATE240311T1 (de) Verfahren zur herstellung von 2-thienylamin- derivaten
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE373071T1 (de) Zusammensetzung und verfahren zur behandlung von halbleitersubstraten
ATE272637T1 (de) Verfahren zur herstellung einer substituierten imidazopyridinverbindung
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
DE50100698D1 (de) Verfahren zur Herstellung von 1,3,6-Hexantricarbonitril
ATE380171T1 (de) Verfahren zur herstellung von terbinafine
ATE528358T1 (de) Verfahren zur herstellung einer azoverbindung
ATE282589T1 (de) Verfahren zur herstellung eines chiralen-beta- aminosäureesters
DE60308204D1 (de) Verfahren zur herstellung von aminopyrrolidinderivaten
DE60125386D1 (de) Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins
ATE251616T1 (de) Verfahren zur herstellung von 5- hydroxymethylthiazole
ATE372974T1 (de) Verfahren zur herstellung von allylethern
RS51050B (sr) Postupak za dobijanje derivata 4-trifluorometilsulfinil pirazola
ATE286881T1 (de) Verfahren zur zyklisierung von optisch aktiven 4- amino-2-halogenbuttersäuren
DE60028998T8 (de) Verfahren zur herstellung einer benzylamin-verbindung
EP1035125A3 (de) 2-Pyridylsilan, Verfahren zur deren Herstellung und Verwendung
DE60306506D1 (de) Verfahren
ATE205497T1 (de) Verfahren zur herstellung von 3-norcephem- verbindungen
DE50205226D1 (de) Verfahren zur herstellung von vanillylamin hydrochlorid
ATE144255T1 (de) Verfahren zur herstellung von pyridazinonderivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties